Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleOriginal Article

A Novel Cyclohexene Derivative, Ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), Selectively Inhibits Toll-Like Receptor 4-Mediated Cytokine Production through Suppression of Intracellular Signaling

Masayuki Ii, Naoko Matsunaga, Kaoru Hazeki, Kazuyo Nakamura, Katsunori Takashima, Tsukasa Seya, Osamu Hazeki, Tomoyuki Kitazaki and Yuji Iizawa
Molecular Pharmacology April 2006, 69 (4) 1288-1295; DOI: https://doi.org/10.1124/mol.105.019695
Masayuki Ii
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naoko Matsunaga
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaoru Hazeki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuyo Nakamura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katsunori Takashima
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tsukasa Seya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Osamu Hazeki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomoyuki Kitazaki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuji Iizawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 69 no. 4 1288-1295
DOI 
https://doi.org/10.1124/mol.105.019695
PubMed 
16373689

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received October 11, 2005
  • Accepted December 22, 2005
  • Published online March 21, 2006.

Article Versions

  • Earlier version (December 22, 2005 - 14:02).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Masayuki Ii,
  2. Naoko Matsunaga,
  3. Kaoru Hazeki,
  4. Kazuyo Nakamura,
  5. Katsunori Takashima,
  6. Tsukasa Seya,
  7. Osamu Hazeki,
  8. Tomoyuki Kitazaki and
  9. Yuji Iizawa
  1. Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Osaka, Japan (M.I., N.M., K.N., K.T., T.K., Y.I.); Division of Molecular Medical Science, Graduate School of Biomedical Sciences, Hiroshima University, Higashi-Hiroshima, Japan (K.H., O.H.); and Department of Microbiology and Immunology, Hokkaido University Graduate School of Medicine, Sapporo, Japan (T.S.)
  1. Address correspondence to:
    Dr. Masayuki Ii, Pharmacology Research Laboratories I, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 17-85, Jusohonmachi 2-chome, Yodogawa-ku, Osaka 532-8686, Japan. E-mail: ii_masayuki{at}takeda.co.jp
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: December 2005 to May 2022

AbstractFullPdf
Dec 2005240118
Jan 2006670355
Feb 2006450221
Mar 20069223162
Apr 2006544968
May 2006412260
Jun 2006372971
Jul 2006382248
Aug 2006651436
Sep 2006582447
Oct 2006662073
Nov 2006803174
Dec 2006712975
Jan 2007752568
Feb 2007682345
Mar 2007462048
Apr 2007494460
May 2007504966
Jun 2007383963
Jul 2007425670
Aug 2007643461
Sep 2007434873
Oct 2007645677
Nov 20077745103
Dec 2007513149
Jan 2008762875
Feb 2008763775
Mar 2008973667
Apr 2008913972
May 20081033059
Jun 2008653652
Jul 20081043266
Aug 20081033728
Sep 2008774947
Oct 2008783441
Nov 2008763852
Dec 2008473022
Jan 2009594543
Feb 20091114168
Mar 2009833947
Apr 2009382443
May 2009432027
Jun 2009372639
Jul 2009583846
Aug 2009463579
Sep 2009632956
Oct 2009613029
Nov 2009571741
Dec 2009611936
Jan 20101271253
Feb 2010642238
Mar 2010573951
Apr 2010493941
May 2010924043
Jun 20101233334
Jul 2010393245
Aug 20101535748
Sep 2010543643
Oct 2010574435
Nov 2010395739
Dec 2010204030
Jan 2011173534
Feb 2011233437
Mar 2011276141
Apr 2011143539
May 2011263536
Jun 2011333042
Jul 2011274830
Aug 2011223345
Sep 2011243255
Oct 2011172843
Nov 2011293940
Dec 2011153131
Jan 2012314238
Feb 2012263332
Mar 2012223841
Apr 201282719
May 2012202545
Jun 2012183647
Jul 2012222241
Aug 2012252530
Sep 2012224040
Oct 2012315741
Nov 2012223741
Dec 2012171829
Jan 2013273444
Feb 2013222329
Mar 2013185355
Apr 2013344844
May 2013153948
Jun 2013162630
Jul 2013152952
Aug 2013312922
Sep 2013182141
Oct 2013121724
Nov 2013282375
Dec 2013163125
Jan 2014293631
Feb 2014143134
Mar 2014204451
Apr 2014286343
May 2014132320
Jun 2014172725
Jul 2014183429
Aug 2014222834
Sep 2014183845
Oct 2014255043
Nov 2014174729
Dec 2014213040
Jan 20153414295
Feb 20154918542
Mar 20155315248
Apr 2015496519
May 2015248632
Jun 20152210641
Jul 2015304447
Aug 2015192826
Sep 2015255034
Oct 2015353642
Nov 2015213429
Dec 2015204439
Jan 2016363534
Feb 2016574446
Mar 2016433848
Apr 2016223741
May 2016344733
Jun 2016232719
Jul 2016322128
Aug 2016253623
Sep 2016223828
Oct 2016165319
Nov 201684629
Dec 201694122
Jan 2017113724
Feb 201745919
Mar 201765030
Apr 201746237
May 201784819
Jun 201786322
Jul 2017145937
Aug 201789037
Sep 201797338
Oct 201718228
Nov 201777929
Dec 201768431
Jan 201857154
Feb 201884924
Mar 2018109543
Apr 201887227
May 201877039
Jun 201865424
Jul 2018136922
Aug 201865727
Sep 201835420
Oct 201869959
Nov 2018138957
Dec 2018583120
Jan 201992118
Feb 2019541521
Mar 2019891312
Apr 20191292116
May 20191101726
Jun 20191041517
Jul 20191151519
Aug 201914196
Sep 2019831814
Oct 2019841918
Nov 20191262917
Dec 201984115
Jan 202058169
Feb 2020102186
Mar 202079136
Apr 20209621
May 202051145
Jun 202089207
Jul 202080166
Aug 20205859
Sep 2020105215
Oct 20206168
Nov 2020102105
Dec 202043117
Jan 202185179
Feb 202183712
Mar 2021119125
Apr 20211022010
May 202162128
Jun 20219175
Jul 202147108
Aug 2021571110
Sep 202162149
Oct 202110557
Nov 2021117165
Dec 20211061114
Jan 202287108
Feb 202275219
Mar 20227365
Apr 20226678
May 202279129

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 69 (4)
Molecular Pharmacology
Vol. 69, Issue 4
1 Apr 2006
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
A Novel Cyclohexene Derivative, Ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), Selectively Inhibits Toll-Like Receptor 4-Mediated Cytokine Production through Suppression of Intracellular Signaling
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleOriginal Article

A Novel Cyclohexene Derivative, Ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), Selectively Inhibits Toll-Like Receptor 4-Mediated Cytokine Production through Suppression of Intracellular Signaling

Masayuki Ii, Naoko Matsunaga, Kaoru Hazeki, Kazuyo Nakamura, Katsunori Takashima, Tsukasa Seya, Osamu Hazeki, Tomoyuki Kitazaki and Yuji Iizawa
Molecular Pharmacology April 1, 2006, 69 (4) 1288-1295; DOI: https://doi.org/10.1124/mol.105.019695

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleOriginal Article

A Novel Cyclohexene Derivative, Ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), Selectively Inhibits Toll-Like Receptor 4-Mediated Cytokine Production through Suppression of Intracellular Signaling

Masayuki Ii, Naoko Matsunaga, Kaoru Hazeki, Kazuyo Nakamura, Katsunori Takashima, Tsukasa Seya, Osamu Hazeki, Tomoyuki Kitazaki and Yuji Iizawa
Molecular Pharmacology April 1, 2006, 69 (4) 1288-1295; DOI: https://doi.org/10.1124/mol.105.019695
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The 73-kDa Heat Shock Cognate Protein Is a CXCR4 Binding Protein that Regulates the Receptor Endocytosis and the Receptor-Mediated Chemotaxis
  • Endogenous Regulator of G-Protein Signaling Proteins Regulate the Kinetics of Gαq/11-Mediated Modulation of Ion Channels in Central Nervous System Neurons
Show more ORIGINAL ARTICLE

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics